XBiotech Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.3% | +0.5% | -5.4% | -2.6% | -5.1% | -8.7% | -1.7% | -3.5% | -13.0% | -6.8% | -4.4% | |
| – | -1.3% | +0.7% | -6.1% | -2.9% | -5.7% | -9.7% | -1.8% | -3.8% | -14.8% | -7.8% | -5.0% | |
| – | -1.1% | +0.5% | -6.2% | -2.9% | -5.7% | -9.7% | -1.9% | -3.6% | -14.8% | -8.0% | -5.1% | |
| – | -1.1% | +0.5% | -6.2% | -2.9% | -5.7% | -9.7% | -1.9% | -3.6% | -14.8% | -8.0% | -5.1% | |
| – | -29.8% | +1.1% | +5.1% | -12.3% | -1.5% | -25.6% | +0.0% | -29.5% | -20.0% | -16.1% | -3.6% | |
| – | +11.9% | +139.1% | +1.5% | -5.9% | -5.1% | -57.5% | -21.4% | -4.9% | +82.1% | -50.5% | +7.7% | |
| – | +15.2% | +176.8% | +1.5% | -6.7% | -5.5% | -64.2% | -28.7% | -7.6% | +122.4% | -62.2% | +11.8% | |
| – | – | – | +0.0% | +0.0% | +2.5% | +0.0% | – | – | – | – | – | |
| – | +71.4% | +3.6% | -34.6% | -11.6% | +47.6% | -50.5% | +30.1% | -27.1% | +47.2% | -44.2% | +28.9% | |
| – | -1.7% | -4.4% | -6.0% | -2.3% | -5.1% | -4.1% | -0.9% | -3.5% | -16.0% | -3.8% | -4.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.1% | 0.0% | +0.1% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.